The Ozempic titration schedule at a glance
The FDA-approved Ozempic titration is deliberately slow. Everyone starts at the same 0.25 mg once-weekly dose for the first 4 weeks, and each subsequent step requires at least 4 weeks at the current dose before moving up. This gradual escalation exists to reduce gastrointestinal side effects such as nausea, not to reach a target as fast as possible.
The label lists three maintenance doses — 0.5 mg, 1 mg, and 2 mg once weekly — and states the prescriber chooses among them 'based on glycemic control.' In other words, there is no single 'correct' Ozempic dose. Many people stay at 0.5 mg or 1 mg indefinitely and never reach 2 mg. Moving up is a clinical decision your prescriber makes, not an automatic progression.
- Start: 0.25 mg once weekly for 4 weeks (initiation only)
- Then: 0.5 mg once weekly for at least 4 weeks
- May increase to: 1 mg once weekly after at least 4 weeks on 0.5 mg
- May increase to: 2 mg once weekly after at least 4 weeks on 1 mg
- Maximum recommended dose: 2 mg once weekly
Why the 0.25 mg starter dose does not treat blood sugar
The 0.25 mg dose is a ramp-up dose, not a treatment dose. The Ozempic prescribing information is explicit: 'The 0.25 mg dose is intended for treatment initiation and is not effective for glycemic control.' Its only job is to let your body get used to semaglutide so the more effective doses are better tolerated.
This is why the schedule holds people at 0.25 mg for a full 4 weeks before the first real maintenance dose of 0.5 mg. Skipping or shortening this phase is a decision only a clinician can make, and self-adjusting the starter phase can increase the risk of nausea, vomiting, and other stomach side effects the slow ramp is designed to avoid.
How high can the Ozempic dose go? The 2 mg maximum
The maximum recommended Ozempic dose is 2 mg once weekly. The 2 mg strength was a later addition to the label (originally the ceiling was 1 mg), and it is reserved for people who need additional glycemic control after at least 4 weeks at 1 mg.
There is a separate, lower ceiling for one specific use. To reduce the risk of sustained kidney-function (eGFR) decline, end-stage kidney disease, and cardiovascular death in people with type 2 diabetes and chronic kidney disease, the label directs a maintenance dose of 1 mg once weekly (reached after at least 4 weeks on 0.5 mg) rather than pushing to 2 mg. Which target applies to you is a clinical judgment, not something to decide from a chart.
Ozempic pens and the 'click counting' question
Ozempic is supplied in pre-filled, single-patient-use pens, and different doses come in different pens. Under the current label, the pen that delivers 0.25 mg and 0.5 mg doses contains 2 mg/3 mL; the 1 mg pen contains 4 mg/3 mL; and the 2 mg pen contains 8 mg/3 mL. Ozempic is also available as single-dose pre-filled syringes of 0.25 mg, 0.5 mg, or 1 mg. Each pen is a distinct product and your pharmacy fills the strength your prescriber wrote.
You may see online advice about 'counting clicks' to split a pen or stretch it into extra doses. This is off-label dose manipulation that the FDA label does not describe or endorse, and pharmacists widely caution against it because it can lead to inaccurate dosing. How to use your specific pen — including priming, injection sites (abdomen, thigh, or upper arm), and needle handling — should come from your pharmacist, prescriber, and the Instructions for Use that ship with the pen, not from a click count you found online.
What the label says about a missed dose
The Ozempic prescribing information gives general, non-personalized guidance for a missed weekly dose: 'If a dose is missed, administer Ozempic as soon as possible within 5 days after the missed dose. If more than 5 days have passed, skip the missed dose and administer the next dose on the regularly scheduled day.' In either case you then resume the normal once-weekly schedule.
The label also notes the day of the week can be changed if needed, as long as there are at least 2 days (more than 48 hours) between two doses. This is reference information from the label, not instructions for your situation — if you miss a dose, contact your prescriber or pharmacist, who knows your full history. Never double up to 'catch up' unless a clinician tells you to.
Ozempic for weight loss vs. Wegovy: different drug, different dosing
Ozempic is FDA-approved for type 2 diabetes (and, in eligible patients, to reduce the risk of major cardiovascular events and to slow chronic kidney disease progression). It is not FDA-approved for weight loss. Using Ozempic for weight management is therefore an off-label use, and any dose chart for weight loss is not backed by an FDA-approved Ozempic indication.
Wegovy is the same active ingredient — semaglutide — but it is the version FDA-approved for chronic weight management, with its own separate titration that climbs to a usual maintenance dose of 2.4 mg once weekly (higher than Ozempic's 2 mg ceiling), plus a newer higher-dose option. Because the two products titrate differently and are approved for different purposes, an Ozempic dosage chart should not be used as a weight-loss dosing plan. If weight management is your goal, that is a conversation to have with a licensed provider about the right medication and dose.
Compounded semaglutide is not the same as Ozempic
Some telehealth services offer 'compounded semaglutide.' Compounded products are prepared by pharmacies and are not FDA-approved finished drugs, so they have not gone through the FDA review for safety, effectiveness, and manufacturing quality that branded Ozempic has. Their concentrations, vial sizes, and dosing instructions can differ from the FDA Ozempic label, which means the titration chart on this page does not necessarily apply to a compounded product.
If you are prescribed a compounded semaglutide, follow the dosing your prescriber and pharmacy provide for that specific product, and ask directly how it compares to the FDA-approved schedule. Do not assume the numbers match.
The one rule this chart cannot replace
This chart reproduces what the FDA-approved label says the standard schedule is. It does not tell you what to take. Your prescriber sets your starting point, decides whether and when to move up, may keep you at a lower dose longer, and may hold or lower your dose because of side effects, kidney function, other medications, or how your blood sugar responds.
Do not start, stop, increase, decrease, or skip an Ozempic dose on your own based on a chart. If you have questions about your dose, timing, side effects, or a missed injection, contact the licensed clinician who prescribed it — that is the person the label puts in charge of your dose.